Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 420

    1.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

    Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

    Diabetes Care. 2001 Mar;24(3):465-71.PMID: 11289469 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

    Diabetes Care. 1998 Aug;21(8):1221-5.PMID: 9702423 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.

    Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J; AusDiab.

    Diabetes Care. 2004 Feb;27(2):367-71.PMID: 14747215 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension?

    Bur A, Herkner H, Woisetschläger C, Vlcek M, Derhaschnig U, Hirschl MM.

    Am J Hypertens. 2003 Apr;16(4):297-301.PMID: 12670746 [PubMed - indexed for MEDLINE]Related articles

    7.

    HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

    Bennett CM, Guo M, Dharmage SC.

    Diabet Med. 2007 Apr;24(4):333-43. Epub 2007 Mar 15. Review. Erratum in: Diabet Med. 2007 Sep;24(9):1054. PMID: 17367307 [PubMed - indexed for MEDLINE]Related articles

    8.

    Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.

    Inoue K, Matsumoto M, Akimoto K.

    Diabet Med. 2008 Oct;25(10):1157-63.PMID: 19046193 [PubMed - indexed for MEDLINE]Related articles

    10.

    Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.

    Kim KS, Kim SK, Lee YK, Park SW, Cho YW.

    Diabet Med. 2008 Aug;25(8):997-1000.PMID: 18959616 [PubMed - indexed for MEDLINE]Related articles

    11.

    Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.

    Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SC, Smith JM.

    Diabet Med. 2009 Feb;26(2):115-21.PMID: 19236612 [PubMed - indexed for MEDLINE]Related articles

    12.

    A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.

    Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M.

    Diabet Med. 2006 Oct;23(10):1151-4.PMID: 16978383 [PubMed - indexed for MEDLINE]Related articles

    13.

    A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

    Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

    J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491. PMID: 16918824 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.

    Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A; SFIDA Study Group--Italian Association of Diabetologists (AMD).

    Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204-11.PMID: 15955469 [PubMed - indexed for MEDLINE]Related articles

    15.

    Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.

    Davidson MB, Schriger DL, Peters AL, Lorber B.

    JAMA. 1999 Apr 7;281(13):1203-10. Erratum in: JAMA 1999 Jun 16;281(23):2187. PMID: 10199430 [PubMed - indexed for MEDLINE]Related articles

    16.

    A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

    Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC.

    Diabetes Care. 1996 Sep;19(9):972-8.PMID: 8875091 [PubMed - indexed for MEDLINE]Related articles

    17.

    Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults.

    Sung KC, Rhee EJ.

    Diabet Med. 2007 Aug;24(8):848-54.PMID: 17650158 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

    Ko GT, Chan JC, Tsang LW, Cockram CS.

    Diabetes Care. 2000 Dec;23(12):1770-3.PMID: 11128350 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese.

    Ko GT, Chan JC, Lau E, Woo J, Cockram CS.

    Diabetes Care. 1997 Feb;20(2):170-2.PMID: 9118766 [PubMed - indexed for MEDLINE]Related articles

    20.

    Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.

    Martin DD, Shephard MD, Freeman H, Bulsara MK, Jones TW, Davis EA, Maguire GP.

    Med J Aust. 2005 May 16;182(10):524-7. Erratum in: Med J Aust. 2005 Jun 20;182(12):656. Bulsara, Max K [added]. PMID: 15896181 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data